Clinical and molecular aspects of motoneurone diseases: animal models, neurotrophic factors and Bcl-2 oncoprotein

Author： Sagot Y.   Vejsada R.   Kato A.C.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.18, Iss.9, 1997-10, pp. : 330-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potentials of neurotrophic factors for diseases of the nervous system

By Gao W-Q.   Weil R.J.   Dugich-Djordjevic M.   Lu B.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 325-338

Informa Healthcare

Access to resources Recommend Favorite

Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 4, 2009-09 ,pp. : 277-284

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotrophic Factors - A Tool for Therapeutic Strategies in Neurological,Neuropsychiatric and Neuroimmunological Diseases?

By  

Current Medicinal Chemistry, Vol. 14, Iss. 22, 2007-09 ,pp. : 2318-2329

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the GABAA Receptor in Anxiety: Evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies

By  

Current Neuropharmacology, Vol. 1, Iss. 3, 2003-09 ,pp. : 267-283

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models of hyperfunctioning parathyroid diseases for drug development

By Imanishi Yasuo   Inaba Masaaki   Kawata Takehisa   Nishizawa Yoshiki  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 7, 2009-07 ,pp. : 727-740

Informa Healthcare

Access to resources Recommend Favorite